Control of gene expression by the retinoic Acid-Related Orphan Receptor alpha in HepG2 human hepatoma cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Chauvet, Caroline ^a,b   Vanhoutteghem, Amandine ^b   Duhem, Christian ^a,c,d   Saint Auret, Gaëlle ^a   Bois Joyeux, Brigitte ^b   Djian, Philippe ^b   Staels, Bart ^a,c,d   Danan, Jean Louis ^b  

^a INSERM   (France)

^b CNRS   (France)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID RELATED ORPHAN RECEPTOR ALPHA; OSTEONECTIN; RORA PROTEIN, HUMAN; TUMOR PROTEIN;

ADENOVIRUS INFECTION; ADIPOQ GENE; AGRP GENE; ARTICLE; CELL ADHESION; CELL GROWTH; CELL STRAIN HEPG2; CIRCADIAN RHYTHM; CONTROLLED STUDY; G6PC GENE; GENE; GENE EXPRESSION REGULATION; GENE NUMBER; GENE TARGETING; GENETIC TRANSFECTION; GLUCOSE HOMEOSTASIS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER CARCINOGENESIS; LPA GENE; NR1D1 GENE; NR1D2 GENE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; RECEPTOR UPREGULATION; SPARC GENE; WEIGHT CONTROL; ADENOVIRUS; CHROMATIN IMMUNOPRECIPITATION; DNA MICROARRAY; DNA RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADENOVIRIDAE; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEONECTIN; PROTEIN BINDING; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 79960812575     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022545     Document Type: Article

References (52)

1. Sonoda J, Pei L, Evans RM, (2008) Nuclear receptors: decoding metabolic disease. FEBS Lett 582: 2-9.
2. Robinson-Rechavi M, Escriva Garcia H, Laudet V, (2003) The nuclear receptor superfamily. J Cell Sci 116: 585-586.
3. Germain P, Staels B, Dacquet C, Spedding M, Laudet V, (2006) Overview of nomenclature of nuclear receptors. Pharmacol Rev 58: 685-704.
4. Nuclear Receptor Nomenclature Committee (1999) A unified nomenclature system for the nuclear receptor superfamilly. Cell 97: 161-163.
5. Becker-Andre M, Andre E, DeLamarter JF, (1993) Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem Biophys Res Commun 194: 1371-1379.
6. Gawlas K, Stunnenberg HG, (2000) Differential binding and transcriptional behaviour of two highly related orphan receptors, ROR alpha(4) and ROR beta(1). Biochim Biophys Acta 1494: 236-241.
7. Giguère V, Tini M, Flock G, Ong E, Evans RM, et al. (1994) Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev 8: 538-553.
8. Kallen J, Schlaeppi JM, Bitsch F, Delhon I, Fournier B, (2004) Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A. J Biol Chem 279: 14033-14038.
9. Wiesenberg I, Missbach M, Kahlen JP, Schrader M, Carlberg C, (1995) Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res 23: 327-333.
10. Gold DA, Gent PM, Hamilton BA, (2007) ROR alpha in genetic control of cerebellum development: 50 staggering years. Brain Res 1140: 19-25.
11. Delerive P, Monte D, Dubois G, Trottein F, Fruchart-Najib J, et al. (2001) The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. EMBO Rep 2: 42-48.
12. Kopmels B, Mariani J, Delhaye-Bouchaud N, Audibert F, Fradelizi D, et al. (1992) Evidence for a hyperexcitability state of staggerer mutant mice macrophages. J Neurochem 58: 192-199.
13. Mamontova A, Seguret-Mace S, Esposito B, Chaniale C, Bouly M, et al. (1998) Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation 98: 2738-2743.
14. Vu-Dac N, Gervois P, Grotzinger T, De Vos P, Schoonjans K, et al. (1997) Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha. J Biol Chem 272: 22401-22404.
15. Besnard S, Silvestre JS, Duriez M, Bakouche J, Lemaigre-Dubreuil Y, et al. (2001) Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha. Circ Res 89: 1209-1215.
16. Bois-Joyeux B, Chauvet C, Nacer-Cherif H, Bergeret W, Mazure N, et al. (2000) Modulation of the far-upstream enhancer of the rat alpha-fetoprotein gene by members of the ROR alpha, Rev-erb alpha, and Rev-erb beta groups of monomeric orphan nuclear receptors. DNA Cell Biol 19: 589-599.
17. Raspé E, Duez H, Gervois P, Fievet C, Fruchart JC, et al. (2001) Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J Biol Chem 276: 2865-2871.
18. Lind U, Nilsson T, McPheat J, Stromstedt PE, Bamberg K, et al. (2005) Identification of the human ApoAV gene as a novel RORalpha target gene. Biochem Biophys Res Commun 330: 233-241.
19. Chauvet C, Bois-Joyeux B, Fontaine C, Gervois P, Bernard MA, et al. (2005) The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha. Mol Endocrinol 19: 2517-2526.
20. Chauvet C, Bois-Joyeux B, Berra E, Pouyssegur J, Danan JL, (2004) The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1. Biochem J 384: 79-85.
21. Kim EJ, Yoo YG, Yang WK, Lim YS, Na TY, et al. (2008) Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling. Arterioscler Thromb Vasc Biol 28: 1796-1802.
22. Duez H, Staels B, (2008) The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism. Diab Vasc Dis Res 5: 82-88.
23. Jetten AM, (2009) Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7: e003.
24. Rambaud J, Triqueneaux G, Masse I, Staels B, Laudet V, et al. (2009) Rev-erbalpha2 mRNA encodes a stable protein with a potential role in circadian clock regulation. Mol Endocrinol 23: 630-639.
25. Kang HS, Angers M, Beak JY, Wu X, Gimble JM, et al. (2007) Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol Genomics 31: 281-294.
26. Delerive P, Chin WW, Suen CS, (2002) Identification of Reverb(alpha) as a novel ROR(alpha) target gene. J Biol Chem 277: 35013-35018.
27. Raspé E, Mautino G, Duval C, Fontaine C, Duez H, et al. (2002) Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor alpha. J Biol Chem 277: 49275-49281.
28. Tai IT, Tang MJ, (2008) SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat 11: 231-246.
29. Hafner M, Zimmermann K, Pottgiesser J, Krieg T, Nischt R, (1995) A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription. Matrix Biol 14: 733-741.
30. Del Rosso M, Fibbi G, Pucci M, Margheri F, Serrati S, (2008) The plasminogen activation system in inflammation. Front Biosci 13: 4667-4686.
31. Lippi G, Franchini M, Salvagno GL, Guidi GC, (2007) Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. Cancer Treat Rev 33: 427-436.
32. Raspé E, Duez H, Mansen A, Fontaine C, Fievet C, et al. (2002) Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcription. J Lipid Res 43: 2172-2179.
33. Shibata R, Ouchi N, Murohara T, (2009) Adiponectin and cardiovascular disease. Circ J 73: 608-614.
34. Kwaan HC, McMahon B, (2009) The role of plasminogen-plasmin system in cancer. Cancer Treat Res 148: 43-66.
35. Wang J, Yin L, Lazar MA, (2006) The orphan nuclear receptor Rev-erb alpha regulates circadian expression of plasminogen activator inhibitor type 1. J Biol Chem 281: 33842-33848.
36. Duez H, Duhem C, Laitinen S, Patole PS, Abdelkarim M, et al. (2009) Inhibition of adipocyte differentiation by RORalpha. FEBS Lett 583: 2031-2036.
37. Chopra AR, Louet JF, Saha P, An J, Demayo F, et al. (2008) Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 322: 1395-1399.
38. Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, et al. (2007) Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 318: 1786-1789.
39. van Schaftingen E, Gerin I, (2002) The glucose-6-phosphatase system. Biochem J 362: 513-532.
40. Chou JY, Mansfield BC, (2008) Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease. Hum Mutat 29: 921-930.
41. Diez JJ, Iglesias P, (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148: 293-300.
42. Semenza GL, (2009) Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24: 97-106.
43. Lau CP, Poon RT, Cheung ST, Yu WC, Fan ST, (2006) SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol 210: 459-468.
44. Frizell E, Liu SL, Abraham A, Ozaki I, Eghbali M, et al. (1995) Expression of SPARC in normal and fibrotic livers. Hepatology 21: 847-854.
45. Camino AM, Atorrasagasti C, Maccio D, Prada F, Salvatierra E, et al. (2008) Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats. J Gene Med 10: 993-1004.
46. Atorrasagasti C, Malvicini M, Aquino JB, Alaniz L, Garcia M, et al. (2010) Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells. Int J Cancer 126: 2726-2740.
47. Moh MC, Lee LH, Yang X, Shen S, (2003) HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells. J Hepatol 39: 580-586.
48. Djian P, Easley K, Green H, (2000) Targeted ablation of the murine involucrin gene. J Cell Biol 151: 381-388.
49. Raspé E, Madsen L, Lefebvre AM, Leitersdorf I, Gelman L, et al. (1999) Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation. J Lipid Res 40: 2099-2110.
50. Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, et al. (1996) Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 70: 4805-4810.
51. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, et al. (1995) E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A 92: 2403-2407.
52. Giraud S, Bienvenu F, Avril S, Gascan H, Heery DM, et al. (2002) Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem 277: 8004-8011.